Alternative Systemic Treatments for Vitiligo: A Review
- 853 Downloads
Vitiligo is a common, acquired disorder of skin pigmentation that can significantly impact quality of life. It often represents a therapeutic challenge, which has resulted in interest in alternative treatments such as herbal and vitamin supplements. In this review, we provide an overview of the most commonly studied complementary agents, describe proposed mechanisms of action, identify potential adverse effects, and discuss the primary evidence supporting their use. Our discussion focuses on l-phenylalanine, Polypodium leucotomos, khellin, Ginkgo biloba, and vitamins and minerals, including vitamins B12, C, and E, folic acid, and zinc used as monotherapy or in combination with other treatments for the management of vitiligo.
KeywordsVitiligo Psoralen Folic Acid Supplementation Ginkgo Biloba Clobetasol Propionate
Compliance with Ethical Standards
No funding was received for the preparation of this review.
Conflict of interest
Brandon E. Cohen, Nada Elbuluk, Euphemia W. Mu, and Seth J. Orlow have no conflicts of interest to disclose that are relevant to the content of this review. In the past 12 months, Dr. Elbuluk has served as a consultant to Suneva, and Dr Orlow has served as a consultant to Dermira, Galderma, GSK/Stiefel, and Provectus.
- 28.Pacifico A, Vidolin AP, Leone G, Iacovelli P. Combined treatment of narrowband ultraviolet B light (NBUVB) phototherapy and oral Polypodium leucotomos extract versus NB UVB phototherapy alone in the treatment of patients with vitiligo. J Am Acad Dermatol. 2009;3(Suppl 1):AB154.Google Scholar
- 29.Reyes E, Jaen P, de las Heras E, Carrion F, Alvarez-Mon M, de Eusebio E, et al. Systemic immunomodulatory effects of Polypodium leucotomos as an adjuvant to PUVA therapy in generalized vitiligo: a pilot study. J Dermatol Sci. 2006;41(3):213–6.Google Scholar
- 60.Yaghoobi R, Omidian M, Bagherani N. Original article title: “Comparison of therapeutic efficacy of topical corticosteroid and oral zinc sulfate-topical corticosteroid combination in the treatment of vitiligo patients: a clinical trial”. BMC Dermatol. 2011;11:7.PubMedCentralCrossRefPubMedGoogle Scholar